# EDGAR Filing Document

**Accession Number:** 0001840877
**File Stem:** 0001104659-25-119019
**Filing Date:** 2025-12
**Character Count:** 9409
**Document Hash:** 4d99a80cd15a1bd1fb1f43a71653a666
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-119019.hdr.sgml**: 20251208

**ACCESSION NUMBER**: 0001104659-25-119019

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251208

**DATE AS OF CHANGE**: 20251208

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Envoy Medical, Inc.
- **CENTRAL INDEX KEY:** 0001840877
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 861369123
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93483
- **FILM NUMBER:** 251554543

**BUSINESS ADDRESS:**
- **STREET 1:** 4875 WHITE BEAR PARKWAY
- **CITY:** WHITE BEAR LAKE
- **STATE:** MN
- **ZIP:** 55110
- **BUSINESS PHONE:** 651-361-8000

**MAIL ADDRESS:**
- **STREET 1:** 4875 WHITE BEAR PARKWAY
- **CITY:** WHITE BEAR LAKE
- **STATE:** MN
- **ZIP:** 55110

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Anzu Special Acquisition Corp I
- **DATE OF NAME CHANGE:** 20210115
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TAYLOR GLEN A
- **CENTRAL INDEX KEY:** 0001213971

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** C/O TAYLOR CORP
- **STREET 2:** 1725 ROE CREST DR
- **CITY:** N MANKALO
- **STATE:** MN
- **ZIP:** 56002

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Envoy Medical, Inc.**

*(Name of Issuer)*

**Class A Common Stock**

*(Title of Class of Securities)*

**29415V109**

*(CUSIP Number)*

**Brian A. Mayer, Esq.**<br>Taylor Corporation<br>1725 Roe Crest Drive<br>North Mankato MN 56003<br>507.386.3193

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/01/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **29415V109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Glen A. Taylor** | Name of reporting person<br>**Glen A. Taylor** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**14659614.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**14659614.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**14659614.00** | Aggregate amount beneficially owned by each reporting person<br>**14659614.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**44.2%** | Percent of class represented by amount in Row (11)<br>**44.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock

**(b) Name of Issuer:**
Envoy Medical, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
4875 White Bear Parkway, White Bear Lake, MN, 55110

As used herein, the term "Company" includes Envoy Medical Corporation ("Legacy Envoy") for all periods prior to the closing of the transactions described in the Business Combination Agreement, dated as of April 17, 2023, as amended by Amendment No. 1 to the Business Combination Agreement, dated May 12, 2023, and Amendment No. 2 to the Business Combination Agreement, dated August 31, 2023, by and among Anzu Special Acquisition Corp I, Envoy Merger Sub, Inc. and Legacy Envoy (the "Business Combination Agreement").

**Item 4. Purpose of Transaction**

The information set forth in Item 3, Item 5 and Item 6 are hereby incorporated by reference in its entirety.

The Reporting Person acquired the securities of the Company for investment purposes, in connection with financing transaction with in the Company and in connection with his role as a director of Legacy Envoy and the Company from 2012 to August 25, 2025.

The Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

However, the Reporting Person may, from time to time, develop plans or proposals to acquire or dispose of securities of the Company. These plans or proposals will depend upon the Reporting Person's continuing assessments of relevant factors, including: the market for the Class A Common Stock; the conversion, exercise or other rights of the Series A Preferred Stock and warrants; the terms of the Voting Agreement: the business and prospects of the Company and its financial performance and condition; other business and investment opportunities available to the Reporting Person; economic conditions; stock market conditions; the actions of the board of directors (the "Board") and members of management of the Company; and the availability and nature of opportunities with respect to the Class A Common Stock and other Company securities beneficially owned by the Reporting Person.

Additionally, the Reporting Person may, from time to time, seek to discuss areas of mutual interest with the Board or management of the Company, which may include items in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

The Reporting Person, at any time and from time to time, may review, reconsider and change his present position or develop such plans or proposals. The Reporting Person, at any time and from time to time, may seek to influence management of the Company or the Board with respect to the business and affairs of the Company and may from time to time consider pursuing or proposing such matters with advisors, the Company or other persons.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information set forth in the cover pages, Item 2 and Item 3 of this Schedule 13D are incorporated herein by reference.

As of December 1, 2025, the Reporting Person beneficially owns an aggregate of 14,659,614 shares of Class A Common Stock, which represents 44.2% of the Class A Common Stock based upon an aggregate of 28,786,511 shares of Class A Common Stock outstanding as of November 10, 2025, as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 filed with the Securities and Exchange Commission on November 10, 2025.

**(b)**
The Reporting Person has sole voting and sole dispositive power over all shares beneficially owned.

**(c)**
None.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Information with respect to the Common Stock Purchase Warrants held by GAT Funding is incorporated herein by reference to Item 3.

The Reporting Person, GAT Funding, and Taylor Sports Group, on the one hand and collectively, the "Taylor Parties," and the Company, on the other hand, are parties to the Voting Agreement. Pursuant to the Voting Agreement, the Taylor Parties agreed to vote any shares beneficially owned by the Taylor Parties in favor of any proposal required to be approved by the Company's stockholders to ensure compliance with certain Nasdaq Listing Rules, provide that the proposal is unanimously approved and recommended by the Board of Directors of the Company. The Taylor Parties' voting obligations will be in effect through December 31, 2028 and will be binding on any transferees of the Class A Common Stock. Under the Voting Agreement, the Company also granted registration rights to the Taylor Parties, under which the Company has agreed to register with the SEC the resale of shares of the Class A Common Stock held by the Taylor Parties upon the request of the Taylor Parties on or after March 31, 2026. Also pursuant to the Voting Agreement, the Company extended the expiration date of warrants held by GAT Funding to purchase an aggregate of 3,500,000 shares of the Company's Class A Common Stock to December 31, 2028.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Glen A. Taylor

**Signature:** /s/ Glen A. Taylor

**Name/Title:** Glen A. Taylor

**Date:** 12/05/2025